HarrisonT. R.: Principles of Internal Medicine;6th edition, McGraw-Hill.
3.
DaleH. H.FeldbergW.VogtM.: J. Physiol.86: 353, 1936.
4.
ElmqvistD.HofmanW. W.KugelbergJ.QuastelD. M. J.: J. Physiol.114: 417, 1964.
5.
EatonL. M.LambertE. H.: Electromyography & Electric Stimulation of Nerves in Diseases of Motor Unit, J. Amer. Med. Assoc.163: 1117, 1957.
6.
KurlandL. T.: The Frequency of Myasthenia Gravis, A Preliminary Appraisal, read at the Annual meeting of the Medical Advisory Board, The Myasthenia Gravis Foundation, Inc., New York, 1957.
7.
OssermanK. E.: Myasthenia Gravis p. 98, Grune & Stratton, New York & London, 1958.
8.
OssermanK. E.GenkinsG.: Studies in Myasthenia Gravis: Review of a Twenty Year Experience in over 1200 Patients, Mt. Sinai J. Med.38: 497–537, 1971.
9.
FlackeW.: Drug Therapy — Treatment of Myasthenia Gravis, New Engl. J. Med.288: 27, 1973.
10.
NastukW. L.OssermanK. E.PlesciaO. J.: Reduction in Serum Complement Concentrations in Myasthenia Gravis, Fed. Proc.15: 1, 1956.
11.
RuleA. H.KornfeldP.: Studies in Myasthenia Gravis: Biologic Aspects, Mt. Sinai J. Med.38: 538–572, 1971.
12.
AviadoD. M.: Pharmacologic Principles of Medical Practice;8th Edition, p. 346, Williams & Wilkins, 1972.
13.
KoelleG. B.: Acetylcholine — Current Status in Physiology, Pharmacology & Medicine, New Engl. J. Med.286: 1086, 1972.
14.
SmithJ. W.: Manual of Medical Therapeutics;19th Edition, p. 367, Little Brown & Company.
15.
ShapiroM. S.NambaT.GrobD.: Corticotrophin Treatment & Thymectomy in Management of Myasthenia Gravis, Arch. Neurology24: 65, 1971.
16.
WarmoltsJ. R.EngelW. K.: Benefit from Alternate Day Prednisone in Myasthenia Gravis, New Engl. J. Med.286: 17, 1972.
17.
JenkinsR. B.: Treatment of Myasthenia Gravis with Prednisone, Lancet1: 765, 1972.
18.
SeyboldM. E.DrachmanD. B.: Gradually Increasing Doses of Prednisone in Myasthenia Gravis, New Engl. J. Med.290: 81, 1974.